You're signed outSign in or to get full access.
Samsara Biocapital, LLC
CIK:0001744967
Venture Capital
$2B AUM
29 holdings
Palo Alto, CA, USA
Samsara BioCapital is a venture capital firm focused on healthcare and biotechnology investments.
Investment Strategy
Venture capital investments in healthcare and biotechnology companies
Latest 13F Filing Activity
Samsara Biocapital, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 29 equity positions with a total 13F market value of $489M. The fund increased holdings in Scholar Rock HLDG Corp., Septerna Inc., Aura Biosciences Inc. among other positions. Samsara Biocapital, LLC reduced exposure to Kalaris Therapeutics Inc., Mineralys Therapeutics Inc., Palvella Therapeutics Inc. Ne among others.
Top Buys
Top Holdings
Equity Positions (29)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
S SRRK | SCHOLAR ROCK HLDG CORP | 40.66% | $198.8M | 5,612,896 | $10.15 | $35.42 | +$18.4M |
M MLYS | MINERALYS THERAPEUTICS INC | 15.70% | $76.8M | 5,674,916 | $15.43 | $13.53 | -$13.3M |
S SEPN | SEPTERNA INC | 6.81% | $33.3M | 3,149,128 | $20.83 | $10.57 | +$15.1M |
K KLRS | KALARIS THERAPEUTICS INC | 6.25% | $30.6M | 11,448,081 | $8.03 | $2.67 | -$61.4M |
N NGNE | NEUROGENE INC | 5.25% | $25.7M | 1,717,127 | $20.29 | $14.95 | +$5.6M |
Industry Allocation
PHARMACEUTICAL PREPARATIONS
+59.9%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+31.4%
Investment Team (3)
| Name | Role | Location | |
|---|---|---|---|
 | Partner | CA , United States | |
M Mike Dybbs | Partner | Burlingame, CA , United States | |
 | Senior Associate | San Francisco, CA , United States |
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more